title: [Ovarian cancer from the standpoint of medical oncology].
abstract: Ovarian cancer is chemosensitive. Staging surgery followed by the first line chemotherapy is recommended no matter the stage. For recurrent disease, it is difficult to prolong the survival by chemotherapy. The goal is palliation. When primary debulking surgery can not be achieved because of patients' status, neoadjuvant chemotherapy followed by interval debulking surgery should be considered, although it is still in clinical-trials.
authors.affiliation: Medical Oncology Division, National Cancer Center Hospital.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Kato
authors.forename: Noriyuki
authors.initials: N
authors.lastname: Katsumata
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016190:Carboplatin / Q000008:administration & dosage; D017024:Chemotherapy, Adjuvant; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy; D017239:Paclitaxel / Q000008:administration & dosage; D024162:Second-Look Surgery
chemical_list: D016190:Carboplatin; D017239:Paclitaxel